Speaker Profile
Ph.D., CO-Founder & CSO, Rubedo Life Sciences
Biography
Marco Quarta, PhD, is a scientist, biotechnology executive, and entrepreneur advancing precision medicine for aging and age-related disease. He is the founding CEO and current Chief Scientific Officer of Rubedo Life Sciences, where he leads the development of first-in-class therapeutics that selectively target pathological senescent cells and restore tissue homeostasis.
From 2008 to 2018, Dr. Quarta led translational research at Stanford University and the VA Palo Alto Center for Tissue Regeneration, Repair, and Restoration, integrating stem cell biology, regenerative medicine, biomarker discovery, and clinical translation. He has authored more than 40 peer-reviewed publications and patents across aging biology, cellular rejuvenation, and tissue repair.
Dr. Quarta also co-founded Turn Biotechnologies, Wetware Concepts, and YEBN. He serves on advisory boards for CIRM’s Cal Poly Bridge Program and the Center for Healthcare Innovation, and is President and co-founder of the Phaedon Institute, advancing longevity medicine through cross-sector collaboration and data-driven approaches to healthy human longevity worldwide.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
